Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral…
Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, have signed a collaboration and licence agreement to…
Read More...
Read More...
